$4950 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Enterprise License

Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) - Global Forecast to 2025
[Lowest Price Guaranteed: $4,950]

Published by MarketsandMarkets: 20 May 2020 | 260999 | In Stock
Related Topics: Abbott , Healthcare

Introduction

“The medical wearables market is expected to grow at a CAGR of 21.4% during the forecast period.”

The global medical wearables market is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a high CAGR of 21.4% during the forecast period of 2020 to 2025. The growing adoption of smartphones, increasing penetration of 3G/4G networks, growing geriatric population and rising focus on patient-centric healthcare delivery.

“Based on device type, the vital signs monitoring segment accounted for the largest share of the market in 2019.”

In 2019, the vital signs monitoring segment accounted for the largest share of the Clinical-Grade market. The large share of this segment can be attributed to the growing use of high-tech devices, which are compact, user-friendly, and come with a better graphical user interface for easy visibility of resulted data are helping to increase the market penetration of clinical-grade wearables. These wearables are playing an integral role in treating and monitoring various medical conditions in patients and driving better health outcomes.

“Based on the product, the patches segment accounted for the largest share of the market in 2019.”

In 2019, the patches segment accounted for the largest share of the Clinical-Grade market. The large share of this segment can be attributed to the growth in the adoption of wearable technology is largely dependent on technological advancements and the ease of use. In the past few years, the clinical-grade wearables market has benefited from the growing penetration of 3G and 4G connections across the globe.

“Based on end-user, Long-term care centers, nursing homes, and assisted-living facilities segment is expected to show the highest growth during the forecast period.”

The long-term care centers, nursing homes, and assisted-living facilities segment is expected to show the highest growth during the forecast period. The highest growth of this segment can be attributed to the increasing number of people requiring long-term care as a result of the rising geriatric population and the increasing incidence of chronic disorders. Population aging is poised to become one of the most significant social transformations of the twenty-first century, with implications for nearly all sectors of society, including labor and financial markets, the demand for goods and services, such as housing, transportation and social protection, as well as family structures and intergenerational ties.

“By region, North America accounted for the largest market share in 2019.” In 2019, North America dominated the clinical-grade wearables market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of North America in the clinical-grade wearables market can be attributed to the high penetration of smartphones, tablets, and other mobile platforms, increasing prevalence of chronic diseases, development & adoption of innovative technologies, and rising government initiatives.

Breakdown of primary participants is as mentioned below:

• By Company Type: Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%

• By Designation: C-level: 45%, Director-level: 30%, and Others: 25%

• By Region: North America: 35%, Europe: 30%, Asia Pacific: 25%, Latin America: 5%, and Middle East & Africa: 5%

The prominent players in this market are Medtronic plc (Ireland), Apple, Inc. (US, DexCom Inc. (US), VitalConnect (US), Masimo Corporation (US), Koninklijke Philips N.V. (Netherlands), iRthym Technologies Inc.(US), Omron Corporation (Japan), BioTelemetry, Inc. (US), Bio-beat Technologies (Israel), GE Healthcare (US), Abbott Laboratories (US) and Vivalnk (US).

Research Coverage:

The report analyzes the clinical-grade wearables market and aims at estimating the current size and future growth potential based on various segments, such as product & service and region. It also covers competitive leadership mapping, which helps in analyzing the position of key market companies as visionary leaders, innovators, dynamic players, and emerging players. The report also provides a competitive analysis of the leading players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

• Market Penetration: Comprehensive information on product portfolios offered by the top players in the clinical-grade wearables market. The report analyzes this market by product & service and region.

• Product Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the clinical-grade wearables industry.

• Market Development: Comprehensive information on the lucrative emerging markets by product & service and region.

• Market Diversification: Exhaustive information about new testing services, recent developments, and investments in the clinical-grade wearables industry.

• Competitive Assessment: In-depth assessment of market shares, growth strategies, service offerings, and capabilities of leading players in the clinical-grade wearables market.

Table of Contents
for Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) - Global Forecast to 2025

  • TABLE OF CONTENTS

    1 INTRODUCTION 18

    1.1 OBJECTIVES OF THE STUDY 18

    1.2 MARKET DEFINITION 19

    1.2.1 MARKETS COVERED 20

    1.2.2 YEARS CONSIDERED FOR THE STUDY 20

    1.3 CURRENCY 21

    1.4 LIMITATIONS 21

    1.5 STAKEHOLDERS 21

    2 RESEARCH METHODOLOGY 22

    2.1 RESEARCH APPROACH 22

    2.1.1 SECONDARY RESEARCH 23

    2.1.1.1 Key data from secondary sources 23

    2.1.2 PRIMARY RESEARCH 24

    2.1.2.1 Key data from primary sources 24

    2.1.2.2 Breakdown of primaries 25

    2.2 MARKET SIZE ESTIMATION 25

    2.2.1 TOP-DOWN APPROACH 26

    2.2.2 GROWTH FORECAST 26

    2.3 DATA TRIANGULATION APPROACH 28

    2.4 MARKET SHARE ESTIMATION 29

    3 EXECUTIVE SUMMARY 30

    4 PREMIUM INSIGHTS 35

    4.1 CLINICAL-GRADE WEARABLES MARKET OVERVIEW 35

    4.2 APAC CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 36

    4.3 GEOGRAPHIC SNAPSHOT OF THE CLINICAL-GRADE WEARABLES MARKET 37

    4.4 REGIONAL MIX:CLINICAL-GRADE WEARABLES MARKET 38

    4.5 CLINICAL-GRADE WEARABLES MARKET: DEVELOPING VS. DEVELOPED MARKETS 39

    5 MARKET OVERVIEW 40

    5.1 INTRODUCTION 40

    5.2 MARKET DYNAMICS 40

    5.2.1 DRIVERS 41

    5.2.1.1 Increasing awareness of fitness and incidence of lifestyle disorders 41

    5.2.1.2 Advent of technologically advanced products 41

    5.2.1.3 Growing geriatric population and incidence of chronic diseases 42

    5.2.1.4 Cost-containment in healthcare delivery 42

    5.2.1.5 Robust penetration of 3G and 4G networks for uninterrupted healthcare services 42

    5.2.2 RESTRAINTS 43

    5.2.2.1 Unfavorable standards and regulations 43

    5.2.2.2 Accuracy, standardization, and analysis of wearable-generated data 43

    5.2.3 OPPORTUNITIES 44

    5.2.3.1 Growing adoption of mobile platforms 44

    5.2.3.2 Increasing adoption of AI and 5G 44

    5.2.4 CHALLENGES 44

    5.2.4.1 Patent protection of clinical-grade wearables 44

    5.2.4.2 Lack of data security and concerns over data theft and healthcare fraud 45

    5.2.4.3 Limited battery life 45

    5.2.4.4 Device design complexity 45

    6 INDUSTRY INSIGHTS 46

    6.1 INDUSTRY TRENDS 46

    6.2 ONCOLOGY - THE NEXT FRONTIER FOR CLINICAL-GRADE WEARABLES 46

    6.3 FUTURE TRENDS IN CLINICAL-GRADE WEARABLES 46

    6.4 INVESTMENTS IN CLINICAL-GRADE WEARABLE STARTUPS 47

    7 CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 48

    7.1 INTRODUCTION 49

    7.2 VITAL SIGN MONITORING DEVICES 49

    7.2.1 MULTIPARAMETER TRACKERS 51

    7.2.1.1 Increase in the prevalence of chronic diseases to drive this market segment 51

    7.2.2 ECG/HOLTER/HEART RATE MONITORS 52

    7.2.2.1 ECG monitors help improve the quality of care by facilitating the continuous monitoring of patients—a key factor driving market growth 52

    7.2.3 BLOOD PRESSURE MONITORS 54

    7.2.3.1 Clinical-grade wearable blood pressure monitors form a popular category as these devices are convenient to use and relatively less expensive 54

    7.2.4 PULSE OXIMETERS 56

    7.2.4.1 Growing adoption of pulse oximeters for self-monitoring purposes to drive growth in this market segment 56

    7.3 GLUCOSE MONITORING DEVICES & INSULIN PUMPS 57

    7.3.1 GROWTH IN THE NUMBER OF DIABETICS PROPELS THE ADOPTION OF BLOOD GLUCOSE MONITORING DEVICES 57

    7.4 FETAL MONITORING & OBSTETRIC DEVICES 59

    7.4.1 RISE IN THE NUMBER OF PRETERM BIRTHS TO DRIVE THIS SEGMENT 59

    7.5 NEUROMONITORING DEVICES 60

    7.5.1 GROWING PREVALENCE OF NEUROLOGICAL DISEASES TO DRIVE THIS SEGMENT 60

    7.6 SLEEP MONITORING DEVICES 62

    7.6.1 CONTINUOUS MONITORING OF SLEEP PATTERNS HELPS IDENTIFY THE ROOT CAUSE OF SLEEP-RELATED DISORDERS, THEREBY AIDING PROPER DISEASE MANAGEMENT 62

    8 CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 64

    8.1 INTRODUCTION 65

    8.2 PATCHES 65

    8.2.1 EASE OF USE, CONVENIENCE, NON-INVASIVENESS, AND COMPACT DESIGN ARE EXPECTED TO DRIVE THE GROWTH OF THIS SEGMENT 65

    8.3 SMARTWATCHES 67

    8.3.1 DATA ACCURACY, LIMITED BATTERY LIFE, AND COMPETITION FROM FITNESS BANDS MAY LIMIT MARKET GROWTH TO A CERTAIN EXTENT 67

    8.4 ACTIVITY MONITORS & WRISTBANDS 68

    8.4.1 INCREASING PREVALENCE OF CHRONIC DISEASES HAS RESULTED IN A SIGNIFICANT INCREASE IN THE DEMAND FOR ACTIVITY MONITORS 68

    8.5 OTHER CLINICAL-GRADE WEARABLES 70

    9 CLINICAL-GRADE WEARABLES MARKET, BY END USER 72

    9.1 INTRODUCTION 73

    9.2 LONG-TERM CARE CENTERS, ASSISTED-LIVING FACILITIES, AND NURSING HOMES 73

    9.2.1 INCREASING NUMBER OF PEOPLE REQUIRING LONG-TERM CARE AS A RESULT OF THE RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH 73

    9.3 HOSPITALS 74

    9.3.1 LEADING HOSPITALS ARE USING WEARABLE TECHNOLOGIES TO TRANSFORM RESIDENT TRAINING AND EMERGENCY MEDICINE COMMUNICATION, WHICH PROVIDES THEM WITH A CRITICAL ADVANTAGE 74

    9.4 AMBULATORY CARE CENTERS 75

    9.4.1 THE SHIFT OF PATIENT CARE FROM INPATIENT TO OUTPATIENT SETTINGS IS DRIVING THE GROWTH OF THIS END USER SEGMENT 75

    9.5 HOME CARE SETTINGS 77

    9.5.1 GOVERNMENT INITIATIVES ARE EXPECTED TO SUPPORT THE MARKET GROWTH 77

    10 CLINICAL-GRADE WEARABLES MARKET, BY REGION 78

    10.1 INTRODUCTION 79

    10.2 NORTH AMERICA 80

    10.2.1 US 83

    10.2.1.1 In 2019, the US accounted for the largest share of the clinical-grade wearables market in North America 83

    10.2.2 CANADA 85

    10.2.2.1 Need to curtail escalating healthcare costs to drive the market in Canada 85

    10.3 EUROPE 88

    10.3.1 GERMANY 90

    10.3.1.1 Need for better and improved healthcare services will drive the adoption of clinical-grade wearables in Germany 90

    10.3.2 UK 93

    10.3.2.1 Clinical-grade wearable devices have witnessed high penetration in the UK 93

    10.3.3 FRANCE 95

    10.3.3.1 Use of telehealth solutions and services through big data to propel market growth 95

    10.3.4 ITALY 97

    10.3.4.1 Increasing government initiatives for the implementation of eHealth technologies to support market growth 97

    10.3.5 SPAIN 99

    10.3.5.1 Spain has one of the highest levels of mobile phone penetration in Europe 99

    10.3.6 REST OF EUROPE (ROE) 102

    10.4 ASIA PACIFIC 104

    10.4.1 JAPAN 107

    10.4.1.1 Japan is a highly developed market for wireless technologies with a rapidly evolving mobile healthcare sector 107

    10.4.2 CHINA 109

    10.4.2.1 Growing focus of public & private players on clinical-grade wearables deployment in China to drive market growth 109

    10.4.3 INDIA 112

    10.4.3.1 Increasing number of initiatives from both government organizations and private players to improve access to healthcare to drive market growth 112

    10.4.4 REST OF ASIA PACIFIC 114

    10.5 LATIN AMERICA 116

    10.5.1 INCREASE IN THE ADOPTION OF MOBILITY SOLUTIONS IN BRAZIL AND MEXICO TO DRIVE GROWTH IN THE CLINICAL-GRADE WEARABLES MARKET 116

    10.6 MIDDLE EAST & AFRICA 118

    10.6.1 GOVERNMENT INVESTMENTS IN BUILDING A HEALTHCARE MOBILITY FRAMEWORK IN THE MEA REGION TO DRIVE MARKET GROWTH 118

    11 COMPETITIVE LANDSCAPE 120

    11.1 OVERVIEW 120

    11.2 MARKET RANKING ANALYSIS 121

    11.3 COMPETITIVE LEADERSHIP MAPPING, 2018 122

    11.3.1 VISIONARY LEADERS 122

    11.3.2 INNOVATORS 122

    11.3.3 EMERGING COMPANIES 122

    11.3.4 DYNAMIC DIFFERENTIATORS 122

    11.4 COMPETITIVE SITUATION AND TRENDS 124

    11.4.1 NEW PRODUCT LAUNCHES & ENHANCEMENTS 124

    11.4.2 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS 125

    11.4.3 ACQUISITIONS 126

    12 COMPANY PROFILES 127

    (Business overview, Products offered, Recent developments & MnM View)*

    12.1 KONINKLIJKE PHILIPS N.V. 127

    12.2 MEDTRONIC PLC 130

    12.3 OMRON HEALTHCARE CO., LTD. (A PART OF OMRON CORPORATION) 133

    12.4 BIOTELEMETRY, INC. 135

    12.5 APPLE, INC. 137

    12.6 GE HEALTHCARE 139

    12.7 ABBOTT LABORATORIES 141

    12.8 DEXCOM, INC. 143

    12.9 IRHYTHM TECHNOLOGIES, INC. 145

    12.10 MASIMO CORPORATION 146

    12.11 PREVENTICE SOLUTIONS, INC. 147

    12.12 CONTEC MEDICAL SYSTEMS CO. LTD. 148

    12.13 BIO-BEAT TECHNOLOGIES 149

    12.14 VITALCONNECT 150

    12.15 MINTTIHEALTH 151

    12.16 BIOTRICITY INC. 152

    12.17 VERILY LIFE SCIENCES (A PART OF ALPHABET INC.) 152

    12.18 CYRCARDIA ASIA LIMITED 152

    12.19 TEN3T HEALTHCARE 153

    12.20 VIVALNK, INC. 153

    *Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.

    13 APPENDIX 154

    13.1 INSIGHTS FROM INDUSTRY EXPERTS 154

    13.2 DISCUSSION GUIDE 155

    13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 159

    13.4 RELATED REPORTS 161

    13.5 AUTHOR DETAILS 162

List Of Tables
in Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) - Global Forecast to 2025

LIST OF TABLES


TABLE 1 CLINICAL-GRADE WEARABLES MARKET SNAPSHOT 30

TABLE 2 MAJOR INVESTMENTS IN START-UP COMPANIES 47

TABLE 3 CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 49

TABLE 4 VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 50

TABLE 5 VITAL SIGN MONITORING DEVICES MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 50

TABLE 6 MULTIPARAMETER TRACKERS OFFERED BY KEY MARKET PLAYERS 51

TABLE 7 MULTIPARAMETER TRACKERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 52

TABLE 8 ECG/HOLTER/HEART RATE MONITORS OFFERED BY KEY MARKET PLAYERS 53

TABLE 9 ECG/HOLTER/HEART RATE MONITORS MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 54

TABLE 10 BLOOD PRESSURE MONITORS OFFERED BY KEY MARKET PLAYERS 55

TABLE 11 BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 55

TABLE 12 PULSE OXIMETERS OFFERED BY KEY MARKET PLAYERS 56

TABLE 13 PULSE OXIMETERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 57

TABLE 14 GLUCOSE MONITORING DEVICES OFFERED BY KEY MARKET PLAYERS 58

TABLE 15 GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 58

TABLE 16 FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY KEY MARKET PLAYERS 59

TABLE 17 FETAL MONITORING & OBSTETRIC DEVICES MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 60

TABLE 18 NEUROMONITORING DEVICES OFFERED BY KEY MARKET PLAYERS 61

TABLE 19 NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 61

TABLE 20 SLEEP MONITORING DEVICES OFFERED BY KEY MARKET PLAYERS 62

TABLE 21 SLEEP MONITORING DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 63

TABLE 22 CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 65

TABLE 23 CLINICAL-GRADE WEARABLE PATCHES BY KEY MARKET PLAYERS 65

TABLE 24 CLINICAL-GRADE WEARABLE PATCHES MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 66

TABLE 25 CLINICAL-GRADE WEARABLE SMARTWATCHES BY KEY MARKET PLAYERS 67

TABLE 26 CLINICAL-GRADE WEARABLE SMARTWATCHES MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 68

TABLE 27 CLINICAL-GRADE WEARABLE ACTIVITY MONITORS & WRISTBANDS BY KEY MARKET PLAYERS 69

TABLE 28 CLINICAL-GRADE WEARABLE ACTIVITY MONITORS & WRISTBANDS MARKET,

BY COUNTRY, 2018–2025 (USD MILLION) 69

TABLE 29 OTHER CLINICAL-GRADE WEARABLES BY KEY MARKET PLAYERS 70

TABLE 30 OTHER CLINICAL-GRADE WEARABLES MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 71

TABLE 31 CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018–2025 (USD MILLION) 73

TABLE 32 CLINICAL-GRADE WEARABLES MARKET FOR LONG-TERM CARE CENTERS, ASSISTED-LIVING FACILITIES, AND NURSING HOMES, BY COUNTRY,

2018–2025 (USD MILLION) 74

TABLE 33 CLINICAL-GRADE WEARABLES MARKET FOR HOSPITALS, BY COUNTRY,

2018–2025 (USD MILLION) 75

TABLE 34 CLINICAL-GRADE WEARABLES MARKET FOR AMBULATORY CARE CENTERS,

BY COUNTRY, 2018–2025 (USD MILLION) 76

TABLE 35 CLINICAL-GRADE WEARABLES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2018–2025 (USD MILLION) 77

TABLE 37 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 81

TABLE 38 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 82

TABLE 39 NORTH AMERICA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 82

TABLE 40 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 82

TABLE 41 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 83

TABLE 42 US: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE WEARABLES MARKET 84

TABLE 43 US: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 84

TABLE 44 US: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 84

TABLE 45 US: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 85

TABLE 46 US: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 85

TABLE 47 CANADA: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE WEARABLES MARKET 86

TABLE 48 CANADA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 87

TABLE 49 CANADA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 87

TABLE 50 CANADA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 87

TABLE 51 CANADA: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 88

TABLE 52 EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 89

TABLE 53 EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 89

TABLE 54 EUROPE: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 89

TABLE 55 EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 90

TABLE 56 EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 90

TABLE 57 GERMANY: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE

WEARABLES MARKET 91

TABLE 58 GERMANY: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 91

TABLE 59 GERMANY: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 92

TABLE 60 GERMANY: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 92

TABLE 61 GERMANY: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 92

TABLE 62 UK: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 93

TABLE 63 UK: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 94

TABLE 64 UK: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 94

TABLE 65 UK: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 94

TABLE 66 FRANCE: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE

WEARABLES MARKET 95

TABLE 67 FRANCE: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 96

TABLE 68 FRANCE: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 96

TABLE 69 FRANCE: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 96

TABLE 70 FRANCE: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 97

TABLE 71 ITALY: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE

WEARABLES MARKET 98

TABLE 72 ITALY: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 98

TABLE 73 ITALY: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 98

TABLE 74 ITALY: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 99

TABLE 75 ITALY: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 99

TABLE 76 SPAIN: HEALTHCARE IT INITIATIVES 100

TABLE 77 SPAIN: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE

WEARABLES MARKET 100

TABLE 78 SPAIN: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 101

TABLE 79 SPAIN: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 101

TABLE 80 SPAIN: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 101

TABLE 81 SPAIN: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 102

TABLE 82 REST OF EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018–2025 (USD MILLION) 102

TABLE 83 REST OF EUROPE: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 103

TABLE 84 REST OF EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 103

TABLE 85 REST OF EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 103

TABLE 86 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY COUNTRY,

2018–2025 (USD MILLION) 106

TABLE 87 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 106

TABLE 88 ASIA PACIFIC: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 106

TABLE 89 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 107

TABLE 90 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 107

TABLE 91 JAPAN: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE

WEARABLES MARKET 108

TABLE 92 JAPAN: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 108

TABLE 93 JAPAN: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 108

TABLE 94 JAPAN: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 109

TABLE 95 JAPAN: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 109

TABLE 96 CHINA: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE

WEARABLES MARKET 110

TABLE 97 CHINA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 110

TABLE 98 CHINA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 111

TABLE 99 CHINA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 111

TABLE 100 CHINA: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 111

TABLE 101 INDIA: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE

WEARABLES MARKET 112

TABLE 102 INDIA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 113

TABLE 103 INDIA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 113

TABLE 104 INDIA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 113

TABLE 105 INDIA: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 114

TABLE 106 REST OF ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018–2025 (USD MILLION) 115

TABLE 107 REST OF ASIA PACIFIC: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 115

TABLE 108 REST OF ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 115

TABLE 109 REST OF ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018–2025 (USD MILLION) 116

TABLE 110 LATIN AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE,

2018–2025 (USD MILLION) 116

TABLE 111 LATIN AMERICA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE,

2018–2025 (USD MILLION) 117

TABLE 112 LATIN AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2018–2025 (USD MILLION) 117

TABLE 113 LATIN AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2018–2025 (USD MILLION) 117

TABLE 114 MIDDLE EAST & AFRICA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018–2025 (USD MILLION) 118

TABLE 115 MIDDLE EAST & AFRICA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 119

TABLE 116 MIDDLE EAST & AFRICA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 119

TABLE 117 MIDDLE EAST & AFRICA: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018–2025 (USD MILLION) 119

TABLE 118 PRODUCT LAUNCHES AND ENHANCEMENTS (2019) 124

TABLE 119 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS (2019) 125

TABLE 120 ACQUISITIONS (2018 & 2019) 126

List Of Figures, Charts and Diagrams
in Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) - Global Forecast to 2025

LIST OF FIGURES


FIGURE 1 CLINICAL-GRADE WEARABLES MARKET SEGMENTATION 20

FIGURE 2 RESEARCH DESIGN 22

FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

AND REGION 25

FIGURE 4 MARKET SIZE APPROACH 1 26

FIGURE 5 MARKET SIZE APPROACH 2 27

FIGURE 6 TOP-DOWN APPROACH 27

FIGURE 7 DATA TRIANGULATION METHODOLOGY 28

FIGURE 8 CLINICAL-GRADE WEARABLES BY DEVICE TYPE, 2020 VS. 2025 (USD BILLION) 31

FIGURE 9 VITAL SIGNS MONITORING MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION) 31

FIGURE 10 CLINICAL-GRADE WEARABLES MARKET, BY END USER,

2020 VS. 2025 (USD BILLION) 32

FIGURE 11 CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT,

2020 VS. 2025 (USD BILLION) 33

FIGURE 12 CLINICAL-GRADE WEARABLES MARKET: REGIONAL SNAPSHOT 34

FIGURE 13 INCREASING GERIATRIC POPULATION AND RISING FOCUS ON PATIENT CENTRIC HEALTHCARE DELIVERY TO DRIVE MARKET GROWTH 35

FIGURE 14 PATCHES COMMANDED THE LARGEST SHARE OF THE APAC PRODUCT

MARKET IN 2019 36

FIGURE 15 MARKET IN JAPAN TO GROW AT THE HIGHEST CAGR DURING

THE FORECAST PERIOD 37

FIGURE 16 ASIA PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING

THE FORECAST PERIOD 38

FIGURE 17 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING

THE FORECAST PERIOD 39

FIGURE 18 CLINICAL-GRADE WEARABLES DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 40

FIGURE 19 GEOGRAPHIC SNAPSHOT OF THE CLINICAL-GRADE WEARABLES MARKET 79

FIGURE 20 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET SNAPSHOT 81

FIGURE 21 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET SNAPSHOT 105

FIGURE 22 PRODUCT LAUNCHES—KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM 2017 TO JANUARY 2020 120

FIGURE 23 CLINICAL GRADE WEARABLES MARKET RANKING ANALYSIS, BY PLAYER, 2019 121

FIGURE 24 CLINICAL GRADE WEARBLES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2018 123

FIGURE 25 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019) 127

FIGURE 26 MEDTRONIC PLC: COMPANY SNAPSHOT (2019) 130

FIGURE 27 OMRON HEALTHCARE CO., LTD.: COMPANY SNAPSHOT (2018) 133

FIGURE 28 BIOTELEMETRY, INC.: COMPANY SNAPSHOT (2018) 135

FIGURE 29 APPLE, INC.: COMPANY SNAPSHOT (2019) 137


FIGURE 30 GE HEALTHCARE: COMPANY SNAPSHOT (2019) 139

FIGURE 31 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 141

FIGURE 32 DEXCOM, INC.: COMPANY SNAPSHOT (2018) 143

FIGURE 33 IRHYTHM TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2018) 145

FIGURE 34 MASIMO CORPORATION: COMPANY SNAPSHOT (2018) 146

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

260999 | MD 7653

Number of Pages

163

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Building Strong Cross-Functional Medical Affairs Teams
IntroductionCould your Medical Affairs team be better integrated for more effective cross-functional...
01 May 2015 by FirstWord Pharma USD $695 More Info
Medical Affairs Reputation (EU5): Biosimilar mAbs in Inflammatory Disorders
IntroductionBased on survey results from 150 rheumatologists, dermatologists, and gastroenterologist...
01 Feb 2015 by FirstWord Pharma USD $5,995 More Info
Physician Views: How do endocrinologists value diabetes-focused medical affairs teams – what could they be doing better?
Scope Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacture...
08 Dec 2014 by FirstWord Pharma USD $695 More Info
Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies
IntroductionAs the cancer drug market continues to face significant challenges in an environment of ...
02 Dec 2014 by FirstWord Pharma USD $3,900 More Info
Reshaping Medical Affairs: delivering value to KOLs and payers
IntroductionHistorically, the key role of Medical Affairs was supporting the initial regulatory appr...
21 Aug 2014 by FirstWord Pharma USD $695 More Info
Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies
IntroductionAs the oncology drug market continues to face significant road bumps in terms of develop...
14 Aug 2014 by FirstWord Pharma USD $3,900 More Info
Physician Views: How do pulmonologists value medical affairs teams – what could they be doing better?
Scope Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacture...
09 Jul 2014 by FirstWord Pharma USD $695 More Info
Physician Views: How do neurologists value multiple sclerosis medical affairs teams – what could they be doing better?
Scope Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacture...
18 Jun 2014 by FirstWord Pharma USD $695 More Info
Physician Views: How do oncologists value medical affairs teams – what could they be doing better?
Scope Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacture...
22 May 2014 by FirstWord Pharma USD $695 More Info
Ensuring Optimal Medical Affairs Performance: Delivering Measurable Value
IntroductionIn this era of transparency, Medical Affairs is rapidly becoming the new voice of Pharma...
01 May 2013 by FirstWord Pharma USD $695 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) - Global Forecast to 2025 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...